Insiders Advisor
  • Stocks
  • World News
  • Business
  • Politics
  • Stocks
  • World News
  • Business
  • Politics

Insiders Advisor

World News

Lawmakers urge Biden to call out more Chinese biotech firms

by April 2, 2024
April 2, 2024
Lawmakers urge Biden to call out more Chinese biotech firms

A Republican and a Democratic member of Congress are calling on the Biden administration to add seven Chinese biotech firms to a list created by the Defense Department to highlight firms it says are allegedly working with Beijing’s military.

In a letter dated March 29 seen by Reuters, Republican Michael Gallagher and Democrat Raja Krishnamoorthi asked Defense Secretary Lloyd Austin to take the action since Beijing could harness the power of biotechnology to strengthen its military.

“Urgent action is needed,” said the lawmakers, who serve as the chairman and ranking member of the Select Committee on the Chinese Communist Party, citing risks that China could “create synthetic pathogens” to gain military advantage.

“The Department of Defense provides responses directly to members of Congress in matters of this kind,” a department spokesman said in a statement. “We have no additional information or further details to release at this time.”

A spokesperson for the Chinese Embassy in Washington said “some people” in the United States should stop suppressing Chinese companies under false pretexts.

“When it comes to ‘using biotech to strengthen its military,’ the US side should reflect on itself, rather than groundlessly attacking and smearing China,” the spokesperson, Liu Pengyu, said in a statement.

The letter is the latest sign of growing concern in Washington about China’s biotech sector.

The US Congress is considering legislation to bar federal agencies from contracting with China’s BGI and WuXi AppTec, among others, as part of an effort to keep China from accessing American genetic data and personal health information.

US intelligence officials in late February told senators working on the bill that Chinese pharmaceutical firm WuXi AppTec had transferred US intellectual property to Beijing without consent, Reuters reported.

Being placed on the Pentagon’s Chinese military-backed companies list doesn’t involve immediate bans. However, it can be a blow to companies’ reputations and represents a warning to US firms considering doing business with them. It could also put pressure on the Treasury Department to sanction them.

In their letter, Gallagher and Krishnamoorthi call for the addition of Innomics and STOmics, which they allege are subsidiaries of BGI. BGI Genomics Co., a publicly listed subsidiary of BGI Group, was added to the list in 2022.

Reuters reported in 2021 that BGI has made sales worldwide of prenatal tests developed in collaboration with China’s military and has used them to collect genetic data from millions of women for sweeping research on traits of populations.

BGI has said it is not controlled by the Chinese government or military and that it respects human rights.

The letter also names Origincell, for allegedly operating a bio-storage cell tank and having ties to the Chinese military and Vazyme Biotech, which allegedly makes bioactive compounds and has investors with ties to the military.

“STOmics Americas is a U.S.-based company that has no operations in China nor any connections whatsoever with the Chinese military,” the BGI Group said in a statement.

The other companies did not immediately respond to requests for comment.

Lawmakers in February asked that WuXi AppTec be considered for the list. The company has said it poses no national security risk to any country. It also has said it is not aware of any unauthorized transfers of any US client’s IP to China. – Reuters

previous post
Green mortgages set to take off as US makes homes fit for future
next post
US, Britain announce partnership on AI safety, testing

Related Posts

One-fifth of Mekong River fish species face extinction

March 4, 2024

Russia refits old tanks after losing 3,000 in...

February 14, 2024

US blocks ceasefire call with 3rd UN veto...

February 21, 2024

Gun-shy Australia, reeling from knife crime, weighs public...

April 18, 2024

Brazil judge opens inquiry into Musk after refusal...

April 8, 2024

S. Korean doctors on mass walkout say they’re...

February 26, 2024

Iberians hit the beaches as temperatures rise 10°C...

April 14, 2024

Special counsel urges US Supreme Court to rebuff...

February 15, 2024

Trump, Biden dominate Super Tuesday contests

March 6, 2024

New Zealand accuses China of hacking parliament, condemns...

March 26, 2024

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Duffy’s DOT accuses Biden, Buttigieg of inflating air traffic controller pipeline: ‘Juiced the numbers’

      August 20, 2025
    • FBI arrests woman on ‘Ten Most Wanted Fugitives’ hiding in India, transports to US for prosecution

      August 20, 2025
    • Vance, White House blast ‘crazy communists’ protesting DC clean-up, terrorizing locals: ‘Stupid White hippies’

      August 20, 2025
    • Ukraine’s stolen children crisis looms large as NATO meets on Russia’s war

      August 20, 2025
    • House Democrat clashes with activists over Israel ‘genocide’ as pro-Palestinian protests derail town hall

      August 20, 2025
    • New Schiff leak claim from whistleblower echoes years of similar accusations

      August 20, 2025

    Categories

    • Business (1,354)
    • Politics (6,805)
    • Stocks (904)
    • World News (461)
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: insidersadvisor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 insidersadvisor.com | All Rights Reserved